# Endo to expand Michigan sterile fill-finish plant with $120M investment

Endo International's subsidiary Par Sterile Products entered a cooperative agreement with the U.S. government to expand its sterile fill-finish manufacturing capacity at its Rochester, Michigan plant. The U.S. government will fund approximately $90 million of the total expected cost of approximately $120 million.

- Type: Expansion
- Announced: 2021-11-17
- Where: Rochester, Michigan, United States
- Value: $120.0M
- Status: announced
- Products: sterile fill-finish manufacturing for mRNA and adenovirus vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Endo International plc](https://endata.com/companies/58647.md)
- [Par Sterile Products](https://endata.com/companies/59052.md)
- [U.S. Government](https://endata.com/companies/46425.md) (partner)

## Sources

- [investor.endo.com](https://investor.endo.com/2021-11-17-Endo-Announces-Fill-Finish-Manufacturing-Agreement-with-U-S-Government-to-Support-Production-of-Critical-Medicines), 2021-11-17: "the U.S. government will fund approximately $90 million of the program's total expected cost of approximately $120 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.